|
Academic/Biomedical Research
News & Jobs
|
|
|
|
|
|
|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Company Profiles
Research Store
Research Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
2/25/2013 8:17:42 AM
A Johnson & Johnson (JNJ) subsidiary has recalled a knee replacement device, placing further pressure on the company's orthopedics business. The component can fracture and lead to "loss of function or loss of limb, infection, compromised soft tissue or death," the U.S. Food and Drug Administration said Friday, though it did not report any deaths from the product. J&J affiliate DePuy Orthopaedics Inc. warned hospitals and surgeons in January of the issue, informing them that they should immediately cease distributing the product and return unused stock to the company. The device, called the LPS Diaphyseal Sleeve, is used to create a better fit and feel for patients receiving knee replacement with the company's LPS System. The FDA classified the recall as class one, the most serious type designation, used when a product problem could cause serious health consequences or death.
|
|
|
|
|
|
|
|
|
|
|